Platform will be piloted in a trial by the University of Chicago studying irritable bowel disorders.
But UK registry data falls short.
Two phase 3 trials set to begin this year
Which initiatives are the most likely to bring life-changing therapies to patients?
Disruptive factors are forcing pharma companies to reassess and redefine how they do business.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.
October 20, 2016
Can medical-grade wearables provide efficient, patient-friendly, and cost-effective solutions in an ever-changing healthcare environment?
Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.